Wenpeng Liu

711 total citations
21 papers, 447 citations indexed

About

Wenpeng Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenpeng Liu has authored 21 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenpeng Liu's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Wenpeng Liu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Wenpeng Liu collaborates with scholars based in China and United States. Wenpeng Liu's co-authors include Juqiang Han, Lei Kang, Tao Wang, Qinong Ye, Yingchun Liang, Wei Zhao, Ling Li, Siyu Chen, Yingying Feng and Xiaojie Xu and has published in prestigious journals such as Journal of Ethnopharmacology, Cancer Letters and Medicine.

In The Last Decade

Wenpeng Liu

21 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenpeng Liu China 11 285 279 44 38 30 21 447
Mengsi Hu China 9 270 0.9× 185 0.7× 35 0.8× 45 1.2× 31 1.0× 20 499
Kristofor A. Olson United States 7 313 1.1× 244 0.9× 45 1.0× 55 1.4× 23 0.8× 12 466
Shaofeng Shui China 14 256 0.9× 225 0.8× 45 1.0× 27 0.7× 90 3.0× 24 498
Juan Jin China 10 377 1.3× 323 1.2× 40 0.9× 52 1.4× 40 1.3× 26 527
Pengxing Zhang China 10 227 0.8× 165 0.6× 27 0.6× 40 1.1× 16 0.5× 20 344
Guan Wang China 9 247 0.9× 245 0.9× 43 1.0× 40 1.1× 31 1.0× 17 399
Quentin Fovez France 6 179 0.6× 114 0.4× 20 0.5× 36 0.9× 32 1.1× 9 316
Yiping Zhu China 13 308 1.1× 260 0.9× 51 1.2× 57 1.5× 15 0.5× 32 456
Ikuo Hirano Japan 12 290 1.0× 225 0.8× 62 1.4× 17 0.4× 27 0.9× 21 772

Countries citing papers authored by Wenpeng Liu

Since Specialization
Citations

This map shows the geographic impact of Wenpeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenpeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenpeng Liu more than expected).

Fields of papers citing papers by Wenpeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenpeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenpeng Liu. The network helps show where Wenpeng Liu may publish in the future.

Co-authorship network of co-authors of Wenpeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenpeng Liu. A scholar is included among the top collaborators of Wenpeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenpeng Liu. Wenpeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Luyuan, et al.. (2023). FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma. Cellular Signalling. 111. 110828–110828. 4 indexed citations
2.
Zeng, Qiang, Jinglin Cao, Xin Zhao, et al.. (2023). Identification of Recurrence-Related mRNAs and Noncoding RNAs in Hepatocellular Carcinoma Following Liver Transplantation. The Turkish Journal of Gastroenterology. 34(4). 394–405. 2 indexed citations
3.
Chen, Yajie, Yang Wang, Ziqiang Cui, et al.. (2023). Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Frontiers in Public Health. 11. 1154837–1154837. 19 indexed citations
4.
Liu, Wenpeng, et al.. (2023). VX-765 inhibits pyroptosis and reduces inflammation to prevent acute liver failure by upregulating PPARα expression. Annals of Hepatology. 28(3). 101082–101082. 11 indexed citations
5.
Cao, Jinglin, et al.. (2023). GANT61, an inhibitor of Gli1, inhibits the proliferation and migration of hepatocellular carcinoma cells. Journal of Investigative Medicine. 72(2). 181–192. 3 indexed citations
6.
Yuan, Xiaoye, et al.. (2023). RNA-Seq and Immune Repertoire Analysis of Normal and Hepatocellular Carcinoma Relapse After Liver Transplantation. International Journal of General Medicine. Volume 16. 4329–4341. 1 indexed citations
7.
Zhao, Xin, Wenpeng Liu, Qiang Zeng, et al.. (2022). Exploring the underlying molecular mechanism of liver cancer cells under hypoxia based on RNA sequencing. BMC Genomic Data. 23(1). 38–38. 2 indexed citations
8.
Liu, Wenpeng, et al.. (2022). Edaravone Ameliorates Cerebral Ischemia–Reperfusion Injury by Downregulating Ferroptosis <i>via</i> the Nrf2/FPN Pathway in Rats. Biological and Pharmaceutical Bulletin. 45(9). 1269–1275. 42 indexed citations
9.
Yuan, Xiaoye, Jinglin Cao, Xin Zhao, et al.. (2021). Mycophenolate mofetil enhances the effects of tacrolimus on the inhibitory function of regulatory T cells in patients after liver transplantation via PD-1 and TIGIT receptors. Immunopharmacology and Immunotoxicology. 43(2). 239–246. 5 indexed citations
10.
11.
Ma, Luyuan, Wenpeng Liu, An Xu, et al.. (2020). Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect. Cancer Science. 111(6). 2028–2040. 21 indexed citations
12.
Zhao, Xin, et al.. (2020). Bioinformatics analysis to reveal key biomarkers for early and late hepatocellular carcinoma. Translational Cancer Research. 9(7). 4070–4079. 4 indexed citations
13.
14.
Zheng, Dong, et al.. (2019). Correlation analysis between the SUVmax of FDG-PET/CT and clinicopathological characteristics in oral squamous cell carcinoma. Dentomaxillofacial Radiology. 48(5). 20180416–20180416. 5 indexed citations
15.
Han, Juqiang, et al.. (2019). Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 43(5). 585–593. 26 indexed citations
16.
17.
Liu, Wenpeng, Lei Kang, Juqiang Han, et al.. (2018). miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect. OncoTargets and Therapy. Volume 11. 1643–1653. 59 indexed citations
18.
Li, Ling, Lei Kang, Wei Zhao, et al.. (2017). miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Cancer Letters. 400. 89–98. 165 indexed citations
19.
Shen, Liwei, et al.. (2017). Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization. Medicine. 96(49). e8973–e8973. 2 indexed citations
20.
Liu, Wenpeng, Xiaodan Jiang, Xiafei Fu, et al.. (2008). Bone marrow stromal cells can be delivered to the site of traumatic brain injury via intrathecal transplantation in rabbits. Neuroscience Letters. 434(2). 160–164. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengsi Hu Breakdown of academic impact, for papers by Kristofor A. Olson Breakdown of academic impact, for papers by Shaofeng Shui Breakdown of academic impact, for papers by Juan Jin Breakdown of academic impact, for papers by Pengxing Zhang Breakdown of academic impact, for papers by Guan Wang Breakdown of academic impact, for papers by Quentin Fovez Breakdown of academic impact, for papers by Yiping Zhu Breakdown of academic impact, for papers by Ikuo Hirano
Rankless by CCL
2026